GlassScriptPhysician profile
James N Palmer
NPI 1447287339
$331,376.56
in general payments reported to CMS, 2019-2025
18 companies · $48K in 2025
The $48K reported for 2025 was more than what 99% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $59K · 2020: $1,262 · 2021: $82K · 2022: $1,892 · 2023: $84K · 2024: $56K · 2025: $48K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $165K · Travel and Lodging: $16K · Food and Beverage: $7,542.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $164,539.00 |
| Travel and Lodging | $15,672.61 |
| Food and Beverage | $7,542.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $266,197.74 | 2019-2025 | |
| Medtronic, INC. | $40,931.62 | 2022-2025 | Propel, Straightshot, Endo-Scrub |
| Acclarent, INC | $16,284.72 | 2019-2024 | Trudi Nav Cable, Trudi Nav Suction, Acclarent Balloon Inflation Device |
| Genzyme Corporation | $1,945.12 | 2024 | |
| Integra Lifesciences Corporation | $1,600.58 | 2024-2025 | Integra, Relieva Spinplus Nav, Inspira Air |
| 3-D Matrix, INC. | $1,523.89 | 2023-2025 | |
| Medtronic USA, INC. | $950.00 | 2020 | |
| Glaxosmithkline, LLC. | $623.37 | 2022-2023 | Nucala |
| Regeneron Pharmaceuticals, INC. | $308.66 | 2024-2025 | Dupixent |
| Aerin Medical INC. | $235.87 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $167.57 | 2024-2025 | Dupixent |
| Janssen Research & Development, LLC | $142.07 | 2025 | |
| Neurent Medical Limited | $140.71 | 2025 | Neuromark System, Neuromark Radiofrequency Console |
| Stryker Corporation | $104.36 | 2025 | Scopis Ent, Xpress Loprofile |
| Baxter Healthcare | $81.87 | 2024 | Perclot |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $49.54 | 2025 | Xhance |
| Medical Device Business Services, INC. | $48.37 | 2023 | Vapr |
| Ethicon US, LLC | $40.50 | 2025 | Harmonic, Echelon; Endopath |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Palmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.